PE-22-28
PE-22-28 is a short neuropeptide with demonstrated effects in cognitive enhancement, neuroprotection, and mood stabilization. It acts by regulating gene expression and protein synthesis in neurons and has shown positive outcomes in memory, focus, and anxiety models. It is typically administered via subcutaneous injection and has a favorable safety profile in animals.
Standard dose: 400 mcg SQ daily for 4–6 weeks. Range: 200–600 mcg daily. Can be repeated every 2–3 months with a 2–4 week rest period between cycles.
PE-22-28cognitive enhancementneurotrophin peptidememory peptide